Velnex Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -63.40%
- Profit Growth -66.55%
- Ebitda -64.51%
- Net Worth 12.38%
- Total Assets 10.02%
About Velnex Life Sciences
Velnex Life Sciences Private Limited (VLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 April 2017 (Seven years and ten months 11 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Krishn Mishra, Vinay Singh, and Rohit Vishwakarma serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2017PTC293899
- Company No.
293899
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
What products or services does Velnex Life Sciences Private Limited offer?
Velnex Life Sciences Private Limited offers a wide range of products and services, including Vitamins & Supplements, Multivitamins.
Who are the key members and board of directors at Velnex Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishn Mishra  | Director | 17-Apr-2017 | Current |
| Vinay Singh | Director | 17-May-2019 | Current |
| Rohit Vishwakarma | Director | 25-Jul-2023 | Current |
Financial Performance of Velnex Life Sciences.
Velnex Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 63.4% decrease. The company also saw a substantial fall in profitability, with a 66.55% decrease in profit. The company's net worth Soared by an impressive increase of 12.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Velnex Life Sciences?
In 2021, Velnex Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Velisca Healthcare Private Limited
Krishn Mishra and Vinay Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Velnex Life Sciences?
Unlock and access historical data on people associated with Velnex Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Velnex Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Velnex Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
